Soluble CD163 Is a Marker of Disease Activity in Early Rheumatoid Arthritis and Reflects TNF-alpha Levels.

Stinne Ravn Greisen, Holger Jon Møller, Kristian Stengaard-Pedersen, Merete Lund Hetland, Kim Hørslev-Petersen, Peter Junker, Mikkel Østergaard, Malene Hvid, Bent Winding Deleuran

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

OriginalsprogEngelsk
Publikationsdato16. okt. 2014
StatusUdgivet - 16. okt. 2014
Begivenhed78th Annual Meeting of the American College of Rheumatology - Boston Convention & Exhibition Center , Boston, USA
Varighed: 14. nov. 201419. nov. 2014
Konferencens nummer: 78

Konference

Konference78th Annual Meeting of the American College of Rheumatology
Nummer78
LokationBoston Convention & Exhibition Center
LandUSA
ByBoston
Periode14/11/201419/11/2014

Citationsformater

Greisen, S. R., Møller, H. J., Stengaard-Pedersen, K., Hetland, M. L., Hørslev-Petersen, K., Junker, P., Østergaard, M., Hvid, M., & Deleuran, B. W. (2014). Soluble CD163 Is a Marker of Disease Activity in Early Rheumatoid Arthritis and Reflects TNF-alpha Levels.. Poster session præsenteret på 78th Annual Meeting of the American College of Rheumatology, Boston, USA.